Loading...

Marion Peters, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentMedicine
Address513 Parnassus Ave, Med Sci
San Francisco CA 94143
Phone415-502-0318
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    HIV status and reproductive aging affect liver fibrosis in HIV/HCV infected women
    NIH/NIAID R21AI088351Mar 15, 2010 - Feb 28, 2013
    Role: Principal Investigator
    NRSA Hepatology Training Grant
    NIH/NIDDK T32DK060414Dec 1, 2001 - Jun 30, 2022
    Role: Co-Principal Investigator
    HCV &ALCHOOL-- EPIDEMIOLOGY &HOST-VIRUS CORRELATES
    NIH/NIAAA R01AA012879Sep 30, 2000 - Jul 31, 2006
    Role: Principal Investigator
    INTESTINAL IMMUNE RESPONSE INFLAMMATORY BOWL DISEASE
    NIH/NIDDK R01DK050976Sep 30, 1995 - Aug 31, 2001
    Role: Principal Investigator
    INTESTINAL IMMUNE RESPONSE IN INFLAMMATORY BOWEL DISEASE
    NIH/NIDDK R01DK043020Jun 25, 1991 - Oct 31, 1995
    Role: Principal Investigator
    UCSF Liver Core Center
    NIH/NIDDK P30DK026743Jul 1, 1985 - May 31, 2018
    Role: Co-Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator
    GENERAL CLINICAL RESEARCH CENTER
    NIH M01RR000036Oct 1, 1974 - Mar 31, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Price JC, Dodge JL, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters M, Noworolski S, Tien PC. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults. AIDS. 2017 Sep 24; 31(15):2119-2125. PMID: 28723710.
      View in: PubMed
    2. Keating SM, Dodge JL, Norris PJ, Heitman J, Gange SJ, French AL, Glesby MJ, Edlin BR, Latham PS, Villacres MC, Greenblatt RM, Peters M. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study. PLoS One. 2017; 12(9):e0181004. PMID: 28902848.
      View in: PubMed
    3. Peters M. Management of Autoimmune Hepatitis in Pregnant Women. Gastroenterol Hepatol (N Y). 2017 Aug; 13(8):504-506. PMID: 28867984.
      View in: PubMed
    4. Peters M, Locarnini S. New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection. Gastroenterol Hepatol (N Y). 2017 Jun; 13(6):348-356. PMID: 28690451.
      View in: PubMed
    5. Naggie S, Marks KM, Hughes M, Fierer DS, Macbrayne C, Kim A, Hollabaugh K, Roa J, Symonds B, Brainard DM, McHutchison JG, Peters M, Kiser JJ, Chung R. Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C. Clin Infect Dis. 2017 04 15; 64(8):1035-1042. PMID: 28329053.
      View in: PubMed
    6. Vergara C, Thio C, Latanich R, Cox AL, Kirk GD, Mehta SH, Busch M, Murphy EL, Villacres MC, Peters M, French AL, Golub E, Eron J, Lahiri CD, Shrestha S, Gustafson D, Young M, Anastos K, Aouizerat B, Kim AY, Lauer G, Thomas DL, Duggal P. Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun. 2017 Mar; 18(2):82-87. PMID: 28300059.
      View in: PubMed
    7. Geha R, Peters M, Gill RM, Dhaliwal G. Histology Rings True. N Engl J Med. 2017 03 02; 376(9):869-874. PMID: 28249146.
      View in: PubMed
    8. Price JC, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters M, Noworolski SM, Tien PC. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection. Hepatology. 2017 Mar; 65(3):853-863. PMID: 27981599.
      View in: PubMed
    9. Kelly EM, Feldstein VA, Etheridge D, Hudock R, Peters M. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B. J Ultrasound Med. 2017 May; 36(5):925-932. PMID: 28151547.
      View in: PubMed
    10. Kardashian A, Ma Y, Scherzer R, Price JC, Sarkar M, Korn N, Tillinghast K, Peters M, Noworolski SM, Tien PC. Sex differences in the association of HIV infection with hepatic steatosis. AIDS. 2017 Jan 28; 31(3):365-373. PMID: 27831949.
      View in: PubMed
    11. Balitzer D, Shafizadeh N, Peters M, Ferrell LD, Alshak N, Kakar S. Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria. Mod Pathol. 2017 May; 30(5):773-783. PMID: 28106105.
      View in: PubMed
    12. Liu J, Goicochea P, Block T, Brosgart CL, Donaldson EF, Lenz O, Gee Lim S, Marins EG, Mishra P, Peters M, Miller V. Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation. J Virus Erad. 2017 Jan 01; 3(1):1-6. PMID: 28275452.
      View in: PubMed
    13. Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters M, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis. 2016 Nov 01; 63(9):1160-1167. PMID: 27506682.
      View in: PubMed
    14. Desai SN, Dodge JL, Landay AL, Glesby MJ, Latham PS, Villacres MC, French AL, Gange SJ, Greenblatt RM, Peters M. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study. Medicine (Baltimore). 2016 Aug; 95(33):e4483. PMID: 27537569.
      View in: PubMed
    15. Valcour VG, Rubin LH, Obasi MU, Maki PM, Peters M, Levin S, Crystal HA, Young MA, Mack WJ, Cohen MH, Pierce CB, Adimora AA, Tien PC. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C. J Acquir Immune Defic Syndr. 2016 Jul 01; 72(3):266-73. PMID: 26885801; PMCID: PMC4911304 [Available on 07/01/17].
    16. French AL, Hotton A, Young M, Nowicki M, Augenbraun M, Anastos K, Seaberg E, Rosenberg W, Peters M. Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection. J Acquir Immune Defic Syndr. 2016 Jul 01; 72(3):274-80. PMID: 26918547; PMCID: PMC4911240 [Available on 07/01/17].
    17. Kelly EM, Dodge JL, Sarkar M, French AL, Tien PC, Glesby MJ, Golub ET, Augenbraun M, Plankey M, Peters M. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women. Clin Infect Dis. 2016 Aug 15; 63(4):512-8. PMID: 27225241; PMCID: PMC4967608 [Available on 08/15/17].
    18. Beck KR, Pantilat SZ, O'Riordan DL, Peters M. Use of Palliative Care Consultation for Patients with End-Stage Liver Disease: Survey of Liver Transplant Service Providers. J Palliat Med. 2016 Aug; 19(8):836-41. PMID: 27092870.
      View in: PubMed
    19. Petersen T, Lee YJ, Osinusi A, Amorosa VK, Wang C, Kang M, Matining R, Zhang X, Dou D, Umbleja T, Kottilil S, Peters M. Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin. AIDS Res Hum Retroviruses. 2016 Jul; 32(7):660-7. PMID: 26974581; PMCID: PMC4931749 [Available on 07/01/17].
    20. Peters M, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV. AIDS. 2016 Mar 13; 30(5):723-9. PMID: 26595542; PMCID: PMC4802865 [Available on 03/13/17].
    21. Kuniholm MH, Ong E, Hogema BM, Koppelman M, Anastos K, Peters M, Seaberg EC, Chen Y, Nelson KE, Linnen JM. Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women. Hepatology. 2016 Mar; 63(3):712-20. PMID: 26646162; PMCID: PMC4764464 [Available on 03/01/17].
    22. Swanson S, Ma Y, Scherzer R, Huhn G, French AL, Plankey MW, Grunfeld C, Rosenberg WM, Peters M, Tien PC. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score. J Infect Dis. 2016 Apr 01; 213(7):1079-86. PMID: 26621911; PMCID: PMC4779303 [Available on 04/01/17].
    23. Lang Kuhs KA, Kuniholm MH, Pfeiffer RM, Chen S, Desai S, Edlin BR, Peters M, Plankey M, Sharp GB, Strickler HD, Villacres MC, Quinn TC, Gange SJ, Prokunina-Olsson L, Greenblatt RM, O'Brien TR. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes. PLoS One. 2015; 10(10):e0138827. PMID: 26431156; PMCID: PMC4592222.
    24. Shah S, Ma Y, Scherzer R, Huhn G, French AL, Plankey M, Peters M, Grunfeld C, Tien PC. Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels. AIDS. 2015 Jul 17; 29(11):1325-33. PMID: 25870985; PMCID: PMC4478137.
    25. Martin P, Lau DT, Nguyen MH, Janssen HL, Dieterich DT, Peters M, Jacobson IM. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clin Gastroenterol Hepatol. 2015 Nov; 13(12):2071-87.e16. PMID: 26188135.
      View in: PubMed
    26. Andersson MI, Rajbhandari R, Kew MC, Vento S, Preiser W, Hoepelman AI, Theron G, Cotton M, Cohn J, Glebe D, Lesi O, Thursz M, Peters M, Chung R, Wiysonge C. Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act. Lancet Glob Health. 2015 Jul; 3(7):e358-9. PMID: 26087980.
      View in: PubMed
    27. Sarkar M, Aouzierat B, Bacchetti P, Prokunina-Olsson L, French A, Seaberg E, O'Brien TR, Kuniholm MH, Minkoff H, Plankey M, Strickler HD, Peters M. Association of IFNL3 and IFNL4 polymorphisms with liver-related mortality in a multiracial cohort of HIV/HCV-coinfected women. J Viral Hepat. 2015 Dec; 22(12):1055-60. PMID: 26115445; PMCID: PMC4618098.
    28. Decaris ML, Emson CL, Li K, Gatmaitan M, Luo F, Cattin J, Nakamura C, Holmes WE, Angel TE, Peters M, Turner SM, Hellerstein MK. Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. PLoS One. 2015; 10(4):e0123311. PMID: 25909381; PMCID: PMC4409311.
    29. Kassaye S, Li Y, Huhn G, Peters M, French AL, Tien PC, Luxon B, Plankey MW. Direct and Indirect Serum Markers of Liver Fibrosis Compared with Transient Elastography among Women in the Women's Interagency HIV Study. J AIDS Clin Res. 2015 Apr; 6(4). PMID: 26251759.
      View in: PubMed
    30. Vijayan T, Zheng P, Nguyen C, Brown AM, Chen YW, Peters M. Survey of Asian patients with hepatitis B infection: limited knowledge of transmission and screening of family members. J Immigr Minor Health. 2015 Feb; 17(1):112-7. PMID: 23913129; PMCID: PMC3880640.
    31. Kuniholm MH, Xie X, Anastos K, Kaplan RC, Xue X, Kovacs A, Peters M, Seaberg EC, French AL, Young MA, Augenbraun M, Martinson JA, Bush KA, Landay AL, Strickler HD. Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women. J Acquir Immune Defic Syndr. 2014 Nov 01; 67(3):295-303. PMID: 25314250; PMCID: PMC4197408.
    32. Campos-Varela I, Peters M, Terrault NA. Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting. Clin Infect Dis. 2015 Jan 01; 60(1):108-16. PMID: 25228702.
      View in: PubMed
    33. Sarkar M, Shvachko VA, Ready JB, Pauly MP, Terrault NA, Peters M, Manos MM. Characteristics and management of patients with chronic hepatitis B in an integrated care setting. Dig Dis Sci. 2014 Sep; 59(9):2100-8. PMID: 24728968; PMCID: PMC4149592.
    34. Wojcik GL, Thio CL, Kao WH, Latanich R, Goedert JJ, Mehta SH, Kirk GD, Peters M, Cox AL, Kim AY, Chung RT, Thomas DL, Duggal P. Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent. Genes Immun. 2014 Apr; 15(4):241-6. PMID: 24622687; PMCID: PMC4308959.
    35. Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters M. Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV Clin Trials. 2013 Nov-Dec; 14(6):274-83. PMID: 24334180; PMCID: PMC4113390.
    36. Guy J, Peters M. Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol (N Y). 2013 Oct; 9(10):633-9. PMID: 24764777; PMCID: PMC3992057.
    37. Lai JC, Kahn JG, Tavakol M, Peters M, Roberts JP. Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2013 Oct; 13(10):2611-8. PMID: 24034208; PMCID: PMC4091990.
    38. Aka PV, Kuniholm MH, Pfeiffer RM, Wang AS, Tang W, Chen S, Astemborski J, Plankey M, Villacres MC, Peters M, Desai S, Seaberg EC, Edlin BR, Strickler HD, Thomas DL, Prokunina-Olsson L, Sharp GB, O'Brien TR. Association of the IFNL4-?G Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. J Infect Dis. 2014 Feb 01; 209(3):350-4. PMID: 23956438; PMCID: PMC3883162.
    39. Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, Cyster JG, Erle DJ, Rosenthal P, Cooper S, Baron JL. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest. 2013 Sep; 123(9):3728-39. PMID: 23925290; PMCID: PMC3754256.
    40. Bailony MR, Scherzer R, Huhn G, Plankey MW, Peters M, Tien PC. Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography. J Infect Dis. 2013 Dec 01; 208(11):1776-83. PMID: 23901097; PMCID: PMC3814832.
    41. Price H, Dunn D, Pillay D, Bani-Sadr F, de Vries-Sluijs T, Jain MK, Kuzushita N, Mauss S, Núñez M, Nüesch R, Peters M, Reiberger T, Stephan C, Tan L, Gilson R. Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis. PLoS One. 2013; 8(7):e68152. PMID: 23874527; PMCID: PMC3707972.
    42. French AL, Evans CT, Agniel DM, Cohen MH, Peters M, Landay AL, Desai SN. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J Infect Dis. 2013 Aug 15; 208(4):679-89. PMID: 23687224; PMCID: PMC3719907.
    43. Kuniholm MH, Parrinello CM, Anastos K, Augenbraun M, Plankey M, Nowicki M, Peters M, Golub ET, Lurain N, Landay AL, Strickler HD, Kaplan RC. Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women. PLoS One. 2013; 8(4):e61973. PMID: 23613990; PMCID: PMC3629158.
    44. Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters M, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DL. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med. 2013 Feb 19; 158(4):235-45. PMID: 23420232; PMCID: PMC3638215.
    45. Sarkar M, Bacchetti P, Tien P, Mileti E, French AL, Edlin BR, Keller M, Seaberg E, Nowicki MJ, Young M, Peters M. Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women. Dig Dis Sci. 2013 May; 58(5):1341-8. PMID: 23179159; PMCID: PMC3663918.
    46. Sarkar M, Bacchetti P, French AL, Tien P, Glesby MJ, Nowicki M, Plankey M, Gange S, Sharp G, Minkoff H, Peters M. Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women. Hepatology. 2012 Nov; 56(5):1699-705. PMID: 22618868; PMCID: PMC3440547.
    47. McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM. Untreated HIV infection is associated with higher blood alcohol levels. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):282-8. PMID: 22495786; PMCID: PMC3723399.
    48. Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters M. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS. 2012 Mar 13; 26(5):599-607. PMID: 22156972; PMCID: PMC3698040.
    49. Thomas DL, Bartlett JG, Peters M, Sherman KE, Sulkowski MS, Pham PA. Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clin Infect Dis. 2012 Apr; 54(7):979-83. PMID: 22173234; PMCID: PMC3404695.
    50. Crystal H, Kleyman I, Anastos K, Lazar J, Cohen M, Liu C, Pearce L, Golub E, Valcour V, Ho A, Strickler H, Peters M, Kovacs A, Holman S, Kreek MJ, Manly J. Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2012 Feb 01; 59(2):149-54. PMID: 22107817; PMCID: PMC3319079.
    51. Mileti E, Rosenthal P, Peters M. Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children. Clin Gastroenterol Hepatol. 2012 Apr; 10(4):417-21.e1-2. PMID: 22179022; PMCID: PMC3321372.
    52. Soriano V, Sherman KE, Rockstroh J, Dieterich D, Back D, Sulkowski M, Peters M. Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. AIDS. 2011 Nov 28; 25(18):2197-208. PMID: 21866039.
      View in: PubMed
    53. Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters M. Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia. J Acquir Immune Defic Syndr. 2011 Nov 01; 58(3):e96-9. PMID: 22005002; PMCID: PMC4120944.
    54. Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, Peters M, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, Carrington M. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis. 2011 Jun 15; 203(12):1807-14. PMID: 21606539; PMCID: PMC3100515.
    55. Coffin CS, Mulrooney-Cousins PM, Peters M, van Marle G, Roberts JP, Michalak TI, Terrault NA. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat. 2011 Jun; 18(6):415-23. PMID: 20626626; PMCID: PMC4142495.
    56. Anthony DD, Umbleja T, Aberg JA, Kang M, Medvik K, Lederman MM, Peters M, Koziel MJ, Overton ET. Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals. Vaccine. 2011 Apr 27; 29(19):3558-63. PMID: 21397720; PMCID: PMC3081920.
    57. Chou HS, Hsieh CC, Yang HR, Wang L, Arakawa Y, Brown K, Wu Q, Lin F, Peters M, Fung JJ, Lu L, Qian S. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology. 2011 Mar; 53(3):1007-19. PMID: 21374665; PMCID: PMC3079329.
    58. Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters M, Sulkowski M, Goodman ZD, Chung RT. Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C). J Acquir Immune Defic Syndr. 2010 Dec 15; 55(5):597-605. PMID: 20921898; PMCID: PMC3017670.
    59. Bhattacharya D, Umbleja T, Carrat F, Chung RT, Peters M, Torriani F, Andersen J, Currier JS. Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):170-5. PMID: 20622678; PMCID: PMC2943974.
    60. Ghotb A, Noworolski SM, Madden E, Scherzer R, Qayyum A, Pannell J, Ferrell L, Peters M, Tien PC. Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):228-31. PMID: 20512045; PMCID: PMC2943991.
    61. Tu Z, Li Q, Chou HS, Hsieh CC, Meyerson H, Peters M, Bu H, Fung JJ, Qian S, Lu L, Lin F. Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology. 2011 Apr; 216(4):528-34. PMID: 20851495; PMCID: PMC3557916.
    62. Overton ET, Kang M, Peters M, Umbleja T, Alston-Smith BL, Bastow B, Demarco-Shaw D, Koziel MJ, Mong-Kryspin L, Sprenger HL, Yu JY, Aberg JA. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. Vaccine. 2010 Aug 02; 28(34):5597-604. PMID: 20600512; PMCID: PMC2943846.
    63. Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters M, Rosen HR, Thomas DL, Thio CL. Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. J Infect Dis. 2010 May 01; 201(9):1371-80. PMID: 20331378; PMCID: PMC2853721.
    64. Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters M, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, Carrington M. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology. 2010 May; 51(5):1514-22. PMID: 20169624; PMCID: PMC2946382.
    65. Peters M, Perrillo RP, Jacobson IM, Ross DB, Doo EC, Murray JS, Wong JB. Entering the new era of therapy for HBV and HCV infections. J Fam Pract. 2010 Apr; 59(4 Suppl):S51-8. PMID: 20398591.
      View in: PubMed
    66. Peters M, Weinbaum C, Tan L, Baine WB, Dienstag JL, Liang TJ, So S. Recommendations for prevention, screening, and diagnosis of HBV and HCV infections. J Fam Pract. 2010 Apr; 59(4 Suppl):S29-35. PMID: 20398588.
      View in: PubMed
    67. Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. J Infect Dis. 2010 Mar; 201(5):712-9. PMID: 20105080; PMCID: PMC2827649.
    68. Peters M. End-stage liver disease in HIV disease. Top HIV Med. 2009 Sep-Oct; 17(4):124-8. PMID: 19890184.
      View in: PubMed
    69. French AL, Lin MY, Evans CT, Benning L, Glesby MJ, Young MA, Operskalski EA, Augenbraun M, Peters M. Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clin Infect Dis. 2009 Jul 01; 49(1):148-54. PMID: 19480573; PMCID: PMC2743413.
    70. Peters M. Special populations with hepatitis B virus infection. Hepatology. 2009 May; 49(5 Suppl):S146-55. PMID: 19399810.
      View in: PubMed
    71. Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, Cohen MH, Peters M, Golub ET, Szczech L. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study. Am J Kidney Dis. 2009 Jul; 54(1):43-50. PMID: 19394735; PMCID: PMC2997705.
    72. Soriano V, Peters M, Zeuzem S. New therapies for hepatitis C virus infection. Clin Infect Dis. 2009 Feb 01; 48(3):313-20. PMID: 19123867.
      View in: PubMed
    73. Soriano V, Peters M, Rockstroh J. Fourth HIV & Hepatitis Coinfection Workshop; June 19-21, 2008; Madrid, Spain. HIV Clin Trials. 2009 Jan-Feb; 10(1):52-62. PMID: 19362997.
      View in: PubMed
    74. Duong TH, Nguyen PH, Henley K, Peters M. Risk factors for hepatitis B infection in rural Vietnam. Asian Pac J Cancer Prev. 2009 Jan-Mar; 10(1):97-102. PMID: 19469633; PMCID: PMC4130560.
    75. Mayo MJ, Parkes J, Adams-Huet B, Combes B, Mills AS, Markin RS, Rubin R, Wheeler D, Contos M, West AB, Saldana S, Getachew Y, Butsch R, Luketic V, Peters M, Di Bisceglie A, Bass N, Lake J, Boyer T, Martinez E, Boyer J, Garcia-Tsao G, Barnes D, Rosenberg WM. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology. 2008 Nov; 48(5):1549-57. PMID: 18846542; PMCID: PMC2597274.
    76. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep; 48(3):819-27. PMID: 18688876; PMCID: PMC4142499.
    77. Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, Mauss S, Rockstroh J. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS. 2008 Jul 31; 22(12):1399-410. PMID: 18614862.
      View in: PubMed
    78. Choi G, Peters M. The challenge of diagnosing autoimmune hepatitis: less is more. Hepatology. 2008 Jul; 48(1):10-2. PMID: 18571784.
      View in: PubMed
    79. Buxbaum J, Qian P, Allen PM, Peters M. Hepatitis resulting from liver-specific expression and recognition of self-antigen. J Autoimmun. 2008 Nov; 31(3):208-15. PMID: 18513923; PMCID: PMC2635013.
    80. Strickler HD, Howard AA, Peters M, Fazzari M, Yu H, Augenbraun M, French AL, Young M, Gange S, Anastos K, Kovacs A. The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women. AIDS. 2008 Feb 19; 22(4):527-31. PMID: 18301066; PMCID: PMC3507535.
    81. Ishida JH, Peters M, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA. Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75. PMID: 18166478; PMCID: PMC3184401.
    82. Peters M. Diagnosis and management of hepatitis B virus and HIV coinfection. Top HIV Med. 2007 Nov-Dec; 15(5):163-6. PMID: 18073452.
      View in: PubMed
    83. Wang B, Dolinski BM, Kikuchi N, Leone DR, Peters M, Weinreb PH, Violette SM, Bissell DM. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology. 2007 Nov; 46(5):1404-12. PMID: 17924447; PMCID: PMC4144397.
    84. Cohen MH, Grey D, Cook JA, Anastos K, Seaberg E, Augenbraun M, Burian P, Peters M, Young M, French A. Awareness of hepatitis C infection among women with and at risk for HIV. J Gen Intern Med. 2007 Dec; 22(12):1689-94. PMID: 17924170; PMCID: PMC2219830.
    85. Peters M, Di Bisceglie AM, Kowdley KV, Flye NL, Luketic VA, Munoz SJ, Garcia-Tsao G, Boyer TD, Lake JR, Bonacini M, Combes B. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology. 2007 Sep; 46(3):769-75. PMID: 17654740; PMCID: PMC4167731.
    86. Tsui JI, French AL, Seaberg EC, Augenbraun M, Nowicki M, Peters M, Tien PC. Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis. 2007 Sep 15; 45(6):736-40. PMID: 17712758; PMCID: PMC4142488.
    87. Sherman KE, Peters M, Koziel MJ. HIV and liver disease forum: conference proceedings. Hepatology. 2007 Jun; 45(6):1566-77. PMID: 17538932; PMCID: PMC2786959.
    88. Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Bräu N, Hatzakis A, Pol S, Rockstroh J. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS. 2007 May 31; 21(9):1073-89. PMID: 17502718.
      View in: PubMed
    89. Behler CM, Vittinghoff E, Lin F, Chung RT, Peters M, Robbins GK, Volberding PA. Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects. Clin Infect Dis. 2007 May 15; 44(10):1375-83. PMID: 17443478; PMCID: PMC4075655.
    90. Koziel MJ, Peters M. Viral hepatitis in HIV infection. N Engl J Med. 2007 Apr 05; 356(14):1445-54. PMID: 17409326; PMCID: PMC4144044.
    91. French AL, Operskalski E, Peters M, Strickler HD, Tien PC, Sharp GB, Glesby MJ, Young M, Augenbraun M, Seaberg E, Kovacs A. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis. 2007 May 15; 195(10):1437-42. PMID: 17436223; PMCID: PMC3133731.
    92. Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters M, Andersen J, Chung RT. Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res. 2007 Apr; 27(4):263-9. PMID: 17477814; PMCID: PMC4066618.
    93. Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters M, Chung RT. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. J Interferon Cytokine Res. 2006 Nov; 26(11):834-8. PMID: 17115902; PMCID: PMC4113398.
    94. Peters M, Andersen J, Lynch P, Liu T, Alston-Smith B, Brosgart CL, Jacobson JM, Johnson VA, Pollard RB, Rooney JF, Sherman KE, Swindells S, Polsky B. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology. 2006 Nov; 44(5):1110-6. PMID: 17058225; PMCID: PMC4114764.
    95. Buxbaum J, Qian P, Khuu C, Shneider BL, Daikh DI, Gershwin ME, Allen PM, Peters M. Novel model of antigen-specific induction of bile duct injury. Gastroenterology. 2006 Dec; 131(6):1899-906. PMID: 17087941; PMCID: PMC4113411.
    96. Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters M. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant. 2006 Sep-Oct; 20(5):617-23. PMID: 16968488; PMCID: PMC4050657.
    97. Fix OK, Peters M, Davern TJ. Eosinophilic hepatitis caused by lamotrigine. Clin Gastroenterol Hepatol. 2006 Apr; 4(4):xxvi. PMID: 16616339; PMCID: PMC4113389.
    98. Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS. 2006 Feb 14; 20(3):345-51. PMID: 16439867; PMCID: PMC4060610.
    99. Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, Cooksley WG, Fried MW, Hadziyannis SJ, Liaw YF, Naoumov NV, Schiff ER, Thio CL, Tsai N, Schalm S. Chronic hepatitis B: a critical appraisal of current approaches to therapy. Clin Gastroenterol Hepatol. 2006 Feb; 4(2):233-48. PMID: 16469685.
      View in: PubMed
    100. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2006 Jan 01; 41(1):31-6. PMID: 16340470; PMCID: PMC4050666.
    101. Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters M, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers RL, Rosoff L, Garcia-Tsao G, Boyer JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, Barnes DS, Bonacini M, Lindsay KL, Mills AS, Markin RS, Rubin R, West AB, Wheeler DE, Contos MJ, Hofmann AF. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology. 2005 Nov; 42(5):1184-93. PMID: 16250039.
      View in: PubMed
    102. Guy JE, Qian P, Lowell JA, Peters M. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl. 2005 Oct; 11(10):1252-7. PMID: 16184542; PMCID: PMC4050662.
    103. Peters M. Managing hepatitis B coinfection in HIV-infected patients. Curr HIV/AIDS Rep. 2005 Aug; 2(3):122-6. PMID: 16091258.
      View in: PubMed
    104. Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ. Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS. 2005 May 20; 19(8):767-73. PMID: 15867490; PMCID: PMC4050654.
    105. Sherman KE, Shire NJ, Rouster SD, Peters M, James Koziel M, Chung RT, Horn PS. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology. 2005 Feb; 128(2):313-27. PMID: 15685543; PMCID: PMC4036101.
    106. Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters M, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004 Jul 29; 351(5):451-9. PMID: 15282352; PMCID: PMC4113392.
    107. Quan DJ, Peters M. Antiviral therapy: nucleotide and nucleoside analogs. Clin Liver Dis. 2004 May; 8(2):371-85. PMID: 15481345.
      View in: PubMed
    108. Combes B, Luketic VA, Peters M, Zetterman RK, Garcia-Tsao G, Munoz SJ, Lin D, Flye N, Carithers RL. Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am J Gastroenterol. 2004 Feb; 99(2):264-8. PMID: 15046215; PMCID: PMC3891562.
    109. Peters M, Hann Hw Hw, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df Df, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology. 2004 Jan; 126(1):91-101. PMID: 14699491.
      View in: PubMed
    110. Morgan TR, Brenner D, Everhart J, French SW, Fried MW, Gretch DR, Koziel MJ, McClain CJ, Peters M, Weinman SA, Lucas DL. Hepatitis C and alcohol: fundamental and translational research directions. Alcohol Clin Exp Res. 2003 Apr; 27(4):726-31. PMID: 12711937.
      View in: PubMed
    111. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters M, Heiken JP, Brown JJ, McFarland EG, Middleton WD, Balfe DM, Ritter JH. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology. 2003 Feb; 226(2):533-42. PMID: 12563151.
      View in: PubMed
    112. Peters M, Terrault NA. Alcohol use and hepatitis C. Hepatology. 2002 Nov; 36(5 Suppl 1):S220-5. PMID: 12407597; PMCID: PMC4123319.
    113. Peters M. Animal models of autoimmune liver disease. Immunol Cell Biol. 2002 Feb; 80(1):113-6. PMID: 11869369.
      View in: PubMed
    114. Rubin DC, Zhang H, Qian P, Lorenz RG, Hutton K, Peters M. Altered enteroendocrine cell expression in T cell receptor alpha chain knock-out mice. Microsc Res Tech. 2000 Oct 15; 51(2):112-20. PMID: 11054861.
      View in: PubMed
    115. Peters M, Shouval D, Bonham A, Vierling JM, Lok AS. Posttransplantation: future therapies. Semin Liver Dis. 2000; 20 Suppl 1:19-24. PMID: 10895440.
      View in: PubMed
    116. Peters M, Singer G, Howard T, Jacobsmeyer S, Xiong X, Gibbs CS, Lamy P, Murray A. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation. 1999 Dec 27; 68(12):1912-4. PMID: 10628774.
      View in: PubMed
    117. Combes B, Markin RS, Wheeler DE, Rubin R, West AB, Mills AS, Eigenbrodt EH, Maddrey WC, Munoz SJ, Garcia-Tsao G, Bonner GF, Boyer JL, Luketic VA, Shiffman ML, Peters M, White HM, Zetterman RK, Carithers RL. The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis. Hepatology. 1999 Sep; 30(3):602-5. PMID: 10462363; PMCID: PMC3935822.
    118. Combes B, Carithers RL, Maddrey WC, Munoz S, Garcia-Tsao G, Bonner GF, Boyer JL, Luketic VA, Shiffman ML, Peters M, White H, Zetterman RK, Risser R, Rossi SS, Hofmann AF. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology. 1999 Jun; 29(6):1649-54. PMID: 10347103; PMCID: PMC4004074.
    119. Peters M. Pathogenesis of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangiopathy. Clin Liver Dis. 1998 May; 2(2):235-47, vii-viii. PMID: 15560030.
      View in: PubMed
    120. Teefey SA, Middleton WD, Crowe TM, Peters M. Doppler sonographic evaluation of the portal vein: effects of intravenous dodecafluoropentane. J Ultrasound Med. 1997 Oct; 16(10):641-5. PMID: 9323668.
      View in: PubMed
    121. Reinhold MI, Lindberg FP, Plas D, Reynolds S, Peters M, Brown EJ. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Cell Sci. 1995 Nov; 108 ( Pt 11):3419-25. PMID: 8586654.
      View in: PubMed
    122. Okuyama S, Rubin D, Woodley M, Peters M. Regional expression of murine intestinal immune cells in normal and isografted intestine. Cell Immunol. 1995 Jul; 163(2):198-205. PMID: 7606793.
      View in: PubMed
    123. Lowell JA, Howard TK, White HM, Shenoy S, Huettner PC, Brennan DC, Peters M. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft. Lancet. 1995 Apr 29; 345(8957):1084-5. PMID: 7715341.
      View in: PubMed
    124. Malizia G, Brunt EM, Peters M, Rizzo A, Broekelmann TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology. 1995 Jan; 108(1):145-56. PMID: 7806036.
      View in: PubMed
    125. Clatch RJ, Krigman HR, Peters M, Zutter MM. Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HIV infection and primary myelodysplasia. Br J Haematol. 1994 Dec; 88(4):685-92. PMID: 7819094.
      View in: PubMed
    126. Secrist H, Egan M, Peters M. Tissue-specific regulation of IL-4 mRNA expression in human tonsil. J Immunol. 1994 Feb 01; 152(3):1120-6. PMID: 7507959.
      View in: PubMed
    127. McCabe RP, Secrist H, Botney M, Egan M, Peters M. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol. 1993 Jan; 66(1):52-8. PMID: 8440073.
      View in: PubMed
    128. Woodle ES, Perdrizet GA, Brunt EM, So SK, Jendrisak MD, McCullough CS, Vehe KL, White HM, Peters M, Mohanakumar T. FK506: inhibition of humoral mechanisms of hepatic allograft rejection. Transplantation. 1992 Aug; 54(2):377-81. PMID: 1379749.
      View in: PubMed
    129. Brunt EM, Peters M, Flye MW, Hanto DW. Day-5 protocol liver allograft biopsies document early rejection episodes and are predictive of recurrent rejection. Surgery. 1992 May; 111(5):511-7. PMID: 1317977.
      View in: PubMed
    130. Woodle ES, Perdrizet GA, Brunt EM, So SK, Jendrisak MD, McCullough CS, Vehe KL, White HM, Peters M, Marsh JW. FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. Transplant Proc. 1991 Dec; 23(6):2992-3. PMID: 1721337.
      View in: PubMed
    131. Ambrus JL, Haneiwich S, Chesky L, McFarland P, Peters M, Engler RJ. Abnormal response to a human B cell growth factor in patients with common variable immunodeficiency (CVI). J Allergy Clin Immunol. 1991 Jun; 87(6):1138-49. PMID: 1646248.
      View in: PubMed
    132. Brunt EM, White H, Marsh JW, Holtmann B, Peters M. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. Hepatology. 1991 Jun; 13(6):1017-21. PMID: 2050317.
      View in: PubMed
    133. Ambrus JL, Peters M, Fauci AS, Brown EJ. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation. J Immunol. 1990 Mar 01; 144(5):1549-53. PMID: 2307833.
      View in: PubMed
    134. Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters M. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology. 1990 Jan; 11(1):59-64. PMID: 2403963.
      View in: PubMed
    135. Peters M, Hoffnagle JH, McGarvey C, Fox I, Gregg RE, Jones EA. Primary biliary cirrhosis: management of an unusual case with severe xanthomata by hepatic transplantation. J Clin Gastroenterol. 1989 Dec; 11(6):694-7. PMID: 2584673.
      View in: PubMed
    136. Peters M, Secrist H, Anders KR, Nash GS, Rich SR, MacDermott RP. Normal human intestinal B lymphocytes. Increased activation compared with peripheral blood. J Clin Invest. 1989 Jun; 83(6):1827-33. PMID: 2498391; PMCID: PMC303902.
    137. Peters M, Ambrus JL, Fauci AS, Brown EJ. The Bb fragment of complement factor B acts as a B cell growth factor. J Exp Med. 1988 Oct 01; 168(4):1225-35. PMID: 3262708; PMCID: PMC2189078.
    138. Perrillo RP, Regenstein FG, Peters M, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. Ann Intern Med. 1988 Jul 15; 109(2):95-100. PMID: 3289433.
      View in: PubMed
    139. Hanson RG, Peters M, Hoofnagle JH. Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis. Hepatology. 1986 Mar-Apr; 6(2):173-9. PMID: 2937707.
      View in: PubMed
    140. Jicha DL, Davis GL, Peters M, Hoofnagle JH, Jones EA. Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis. J Interferon Res. 1986 Feb; 6(1):13-20. PMID: 3084673.
      View in: PubMed
    141. Hoofnagle JH, Davis GL, Hanson RG, Pappas SC, Peters M, Avigan MI, Waggoner JG, Howard R, Jones EA, Straus SE. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate. J Med Virol. 1985 Feb; 15(2):121-8. PMID: 2579192.
      View in: PubMed
    Marion's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP